Shane Albright

Shane Albright is a partner in Goodwin’s Life Sciences group. He represents life science and technology companies in a wide range of corporate, financing, licensing and commercial matters, with a particular emphasis on complex corporate partnering transactions. He has extensive experience counseling clients on collaborations, strategic alliances, joint ventures, royalty financings, licenses, and key commercial relationships, such as manufacturing and distribution arrangements.

Shane’s clients include companies in the biopharmaceutical, medical device, diagnostics, hardware, software, medical instrumentation, digital health, vaccine, and research reagent spaces, as well as entities that fund or conduct medical research.

JD, Stanford Law School (with distinction) 2002; Doctor of Philosophy, University of California, Berkeley 1999; BS, Biological Sciences, Stanford University (with distinction) 1991